Not known Facts About how to use mounjaro
The trial reached both equally its Key endpoints, with semaglutide two.4 mg demonstrating statistically major and superior advancements in liver fibrosis without having worsening of steatohepatitis, and also resolution of steatohepatitis without worsening of liver fibrosis in people with MASH when compared to placebo.oneI have the very same problem